NIH/National Institute of Allergy and Infectious Diseases

Diseases, Conditions, Syndromes

NIH begins testing Ebola treatment in early-stage trial

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The Phase 1 clinical trial is examining the safety ...

Diseases, Conditions, Syndromes

Ebola virus infects reproductive organs in monkeys

Ebola virus can infect the reproductive organs of male and female macaques, according to a study published in The American Journal of Pathology, suggesting that humans could be similarly infected. Prior studies of survivors ...

HIV & AIDS

Novel antibody may suppress HIV for up to four months

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months in people undergoing a short-term pause in their antiretroviral therapy (ART) ...

HIV & AIDS

Study of antibody evolution charts course toward HIV vaccine

In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2. Many researchers believe ...

page 6 from 40